Avid Bioservices Inc (CDMO) Inventory Turnover Ratio, from second quarter 2025 to second quarter 2024, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket
 
Avid Bioservices Inc   (NASDAQ: CDMO)
 

Avid Bioservices Inc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Avid Bioservices Inc inventory turnover ratio, the Avid Bioservices Inc 's ability to sell and replace its inventory in the second quarter 2025, sequentially increased to 4.55 in the second quarter 2024, CDMO's markets remain strong, its supply chain continue to be in a grate shape.Average inventory processing period, for the Avid Bioservices Inc in Oct 31 2024 quarter, has decreased to 80 days, compare to 91 days, in the Jul 31 2024 quarter.

Within Healthcare sector 79 other companies have achieved higher inventory turnover ratio. While in terms of ranking among all other companies, the company has moved form 730 in the first quarter 2025, to 801.

CDMO Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Avid Bioservices Inc Market Share?

What is Inventory Turnover Ratio?




CDMO Inventory Turnover Ratio (Oct 31 2024)
II. Quarter
(Jul 31 2024)
I. Quarter
(Apr 30 2024)
IV. Quarter
(Jan 31 2024)
III. Quarter
(Oct 31 2023)
II. Quarter
Y / Y Inventory Growth -27.24 % -28.56 % -30.82 % -23.36 % -1.22 %
Y / Y Cost of Sales Growth 18.42 % 4.42 % 24.09 % 9.96 % -1.99 %
Inventory Turnover Ratio (TTM) 4.55 4.02 3.66 3.16 2.89
CDMO's Total Ranking # 801 # 730 # 846 # 1262 # 1149
Average inventory processing period 80 91 100 116 126
Seq. Inventory Growth -3.85 % -3.88 % -12.13 % -10.41 % -5.59 %
Seq. Cost of Sales Growth 3.1 % -9.32 % 22.58 % 3.33 % -9.09 %




Inventory Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 20
Healthcare Sector # 80
Overall Market # 801

Inventory Turnover Ratio Statistics
High Average Low
6.99 3.42 1.24
(Oct 31 2019)   (Jul 31 2016)




Financial Statements
Avid Bioservices Inc 's Inventories $ 28 Millions Visit CDMO's Balance sheet
Avid Bioservices Inc 's Cost of Revenues TTM $ 139 Millions Visit CDMO's Income Statement
What are CDMO's Sales? Visit CDMO's Sales by Segment

Other Inventory Turnover Ratios
Avid Bioservices Inc 's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Major Pharmaceutical Preparations Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
CDMO's Inventory Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for CDMO's Competitors
Inventory Turnover Ratio for CDMO's Suppliers
Inventory Turnover Ratio for CDMO's Customers

You may also want to know
CDMO's Sales Growth Rates CDMO's Pe Price to earnings ratio CDMO's Receivables Turnover Ratio CDMO's Stock Quote
CDMO's Net Income Growth Rates CDMO's Ps Price to Sales ratio CDMO's Sales per Employee CDMO's Asset Turnover Ratio
CDMO's Net Margin CDMO's Pb Price to Book ratio CDMO's Financial Strength Ratios CDMO's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Oct 31 2024, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Oct 31 2024 Inventories at quarter ending Oct 31 2024
Electromedical Technologies Inc   12.74 $ 0.545  Millions$ 0  Millions
Irhythm Holdings Inc   12.09 $ 179.245  Millions$ 15  Millions
Earth Science Tech Inc   11.93 $ 2.975  Millions$ 0  Millions
Puma Biotechnology Inc   11.55 $ 74.806  Millions$ 6  Millions
Sunlink Health Systems Inc   11.49 $ 17.957  Millions$ 2  Millions
Cryo cell International Inc   11.32 $ 8.387  Millions$ 1  Millions
Genedx Holdings Corp   10.42 $ 108.097  Millions$ 10  Millions
Myriad Genetics Inc   10.28 $ 254.100  Millions$ 25  Millions
Infusystem Holdings Inc  10.04 $ 65.716  Millions$ 7  Millions
Blue Water Vaccines Inc  9.99 $ 2.603  Millions$ 0  Millions
Sotera Health Company  9.51 $ 501.913  Millions$ 53  Millions
Agape Atp Corporation  9.50 $ 0.519  Millions$ 0  Millions
Star Equity Holdings Inc   8.41 $ 40.914  Millions$ 5  Millions
Mangoceuticals Inc   8.33 $ 0.125  Millions$ 0  Millions
Vanda Pharmaceuticals Inc   8.20 $ 12.184  Millions$ 1  Millions
Lifemd Inc   8.13 $ 20.000  Millions$ 2  Millions
Inogen Inc   7.88 $ 184.910  Millions$ 23  Millions
National Vision Holdings Inc   7.83 $ 816.552  Millions$ 104  Millions
Lantheus Holdings Inc   7.65 $ 526.239  Millions$ 69  Millions
Nutriband Inc   7.59 $ 1.383  Millions$ 0  Millions
Carlisle Companies Incorporated  7.53 $ 3,106.300  Millions$ 413  Millions
Castle Biosciences Inc   7.48 $ 56.445  Millions$ 8  Millions
Jrsis Health Care Corp  7.30 $ 3.029  Millions$ 0  Millions
Kewaunee Scientific Corporation  7.26 $ 146.000  Millions$ 20  Millions
Eton Pharmaceuticals Inc   7.21 $ 13.042  Millions$ 2  Millions
Charles River Laboratories International inc   7.19 $ 2,564.710  Millions$ 357  Millions
23andme Holding Co  7.07 $ 102.000  Millions$ 14  Millions
Collegium Pharmaceutical Inc   6.92 $ 224.115  Millions$ 32  Millions
Bionexus Gene Lab Corp   6.91 $ 8.011  Millions$ 1  Millions
Cardiff Lexington Corporation  6.78 $ 3.659  Millions$ 1  Millions

Date modified: 2026-08-29T17:15:55+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.